Quantcast

Latest chemotherapy Stories

2014-02-25 12:27:52

Hyperthermia has shown to greatly improve cancer treatment outcomes when combined with radiation and chemotherapy, but Beverly Hills Thermal Medicine is one of only a few centers to offer it. BEVERLY HILLS, Calif., Feb. 25, 2014 /PRNewswire/ -- /Beverly Hills Thermal Medicine/- Hyperthermia treatments have shown to double response rates of chemotherapy and radiation without side effects, and are an integral part of cancer treatment in Europe, but despite this, it has not gained...

2014-02-22 23:01:25

Careful screening is recommended to protect Non-Hodgkin’s Lymphoma patients against this dangerous side effect of rituximab. Raleigh, NC (PRWEB) February 22, 2014 The Non-Hodgkin’s Lymphoma Center is reporting on a newly-published article illustrating the potential dangers of rituximab therapy. Rituximab is a monoclonal antibody that is often used along with traditional chemotherapy in the treatment of Non-Hodgkin’s Lymphoma and other cancers involving the immune system B-cells....

2014-02-20 12:28:45

PHILADELPHIA, Feb. 20, 2014 /PRNewswire/ -- MS -- According to a new report from the World Health Organization, cancer cases are expected to surge by 20 percent over the next two decades. The World Cancer Report, produced by the WHO's specialized cancer agency, predicts that new cancer cases will rise from 14 million annually in 2012 to 22 million within 20 years, leaving millions more to cope with the disease and the often debilitating and painful side effects of treatment plans that...

2014-02-18 23:24:32

A new study in ovarian cancer patients appears to back up previous research on the value of Vitamin C in the treatment of mesothelioma and other cancers. Raleigh, NC (PRWEB) February 18, 2014 Surviving Mesothelioma is reporting on new research at the University of Kansas that intravenous Vitamin C produces therapeutic levels of the cancer-fighter in the blood, tissue and interstitial fluid (around cells) and kills ovarian cancer cells. The researchers found that Vitamin C damaged the DNA...

2014-02-18 08:31:32

Met Primary Endpoint of Statistically Significant Reduction in Mouth and Throat Soreness Associated With Oral Mucositis; MuGard Patients Also Had Decreased Severity of Oral Mucositis by WHO Score NEW YORK, Feb. 18, 2014 /PRNewswire/ -- ACCESS PHARMACEUTICALS, INC. (OTCBB: ACCP) announced the online early publication of the final results of its post-approval marketing study of MuGard(®) in Cancer, the journal of the American Cancer Society and one of the oldest peer-reviewed journals...

2014-02-12 08:28:26

- BL-8040 study published in Molecular Cancer Therapeutics - JERUSALEM, Feb. 12, 2014 /PRNewswire/ -- BioLineRx (NASDAQ: BLRX; TASE: BLRX), a clinical-stage biopharmaceutical company dedicated to identifying, in-licensing and developing promising therapeutic candidates, announced today positive pre-clinical results for BL-8040 in a third indication - as a treatment for chronic myeloid leukemia. Results of the study were recently published in Molecular Cancer Therapeutics. (Logo:...

2014-02-04 08:34:50

LONDON, Feb. 4, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H2, 2013 Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H2, 2013SummaryGlobalData's clinical trial report, "Chemotherapy Induced Nausea and Vomiting Global Clinical Trials Review, H2, 2013" provides data on the Chemotherapy Induced Nausea and Vomiting clinical trial scenario. This report...

2014-02-03 12:29:37

Co-inventors of ATM technology joining company as General Manager of the ATM Program, Scientific Advisory Panel member, respectively SYDNEY, Feb. 3, 2014 /PRNewswire/ -- Novogen Limited (ASX: NRT; NASDAQ: NVGN), an oncology drug development company, today announced the appointments of Justine Stehn, PhD and Professor Peter Gunning, PhD to roles within the Company. Dr. Stehn and Professor Gunning are the co-inventors of the anti-tropomyosin (ATM) drug technology platform that Novogen...

2014-01-29 16:28:12

DUBLIN, January 29, 2014 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/5s2nhx/drug_delivery_in) has announced the addition a new report "Drug Delivery in Cancer - Technologies, Markets and Companies" [http://www.researchandmarkets.com/research/5s2nhx/drug_delivery_in ] to their offering. (Logo: http://photos.prnewswire.com/prnh/20130307/600769 ) Drug delivery remains a challenge in management of cancer. Approximately 12.5...

2014-01-29 13:16:56

A University of Colorado Cancer Center study published today in the International Journal of Radiation Oncology Biology and Physics shows that patients taking crizotinib for ALK+ non-small cell lung cancer may safely and durably use up to three courses of targeted radiation therapy to eradicate pockets of drug-resistant disease. Eliminating these pockets of resistant disease allows patients to continue treating the overall condition with crizotinib, leading to improved 2-year survival rates...


Latest chemotherapy Reference Libraries

Intravenous Therapy
2013-04-30 13:16:16

Intravenous therapy, commonly known as IV therapy, is known as the administration of a liquid substance directly into a vein. It is also known as drip therapy, because most often the liquid is suspended above the IV site by an infusion pump, and runs through a drip chamber, which prevents air from entering the line. IVs are the preferred method of drug administration in hospital settings because they are the fastest known route of getting medication to the body. Intravenous therapy can also...

Antiviral Chemistry & Chemotherapy
2012-04-25 09:59:26

Antiviral Chemistry & Chemotherapy is a peer-reviewed academic journal published bi-monthly by International Medical Press in London since 1997. When founded in January 1990, it was published by Blackwell Science. The current editor-in-chief is Hugh J. Field of University of Cambridge, UK. The journal publishes primary papers and reviews on all aspects of the preclinical development of antiviral agents, including their chemical synthesis, biochemistry, pharmacology, mode of action and...

More Articles (2 articles) »
Word of the Day
drawcansir
  • A blustering, bullying fellow; a pot-valiant braggart; a bully.
This word is named for Draw-Can-Sir, a character in George Villiers' 17th century play The Rehearsal.
Related